euroPCR 2012.

The most relevant news daily report fromthe EuroPCR congress, held in Paris from the15th to 18th May 2012.

To close a brilliant event, EuroPCR authorities invited the presidents of the European and American societies represented in Paris to a gala tribute dinner at La Maison de l’ Amérique Latine, a magnificent mansion built with the support of Latin American ambassadors in the mid-20th century. The former presidents of the American College of Cardiology, Dr. Spencer King and Dr. David Holmes, also made the honors. Dr. Oscar Mendiz was there representing SOLACI, for Latin America.

If you cannot view the articles, click here

Previous article
Next article

More articles by this author

EuroPCR 2024

Here are the most important scientific articles of the EuroPCR 2024 Scientific Sessions. If you cannot view the articles, click here

ACC 2024

Here are the most important scientific articles of the ACC 2024 Scientific Sessions. If you cannot view the articles, click here

AHA 2023

Here are the most important scientific articles of the AHA 2023 Congress. If you cannot view the articles, click here

TCT 2023

Here are the most important scientific articles of the TCT 2023 Congress. If you cannot view the articles, click here

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....